Investment Ally Bridge Backs Go-Private Deal of Chinese Pharmaceutical Firm Luoxin March 15, 2017 — 03:15
Fund News China Summit Capital Joins $10M Series B Round In Impact Therapeutics February 22, 2016 — 14:05
